Apologies for any offense caused.
Sticking to the main story here, I am amazed Biocryst Management are burning shareholder funds plowing ahead with their preclinical program given the uncertainty.
They will have this in the clinic by early next year.
Whats Biota's game re this? They arent serious about developing a Nuc program?
Looking for a juicy financial settlement??
Add to My Watchlist
What is My Watchlist?